[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100545645":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":21,"locations":30,"responsibleParty":46,"collaborators":20,"id":48,"slug":20,"hasResults":49,"nctId":50,"briefTitle":51,"officialTitle":52,"acronym":20,"eligibilityCriteria":53,"healthyVolunteers":49,"sex":54,"minAge":55,"maxAge":20,"enrollmentInfo":56,"targetDuration":20,"studyType":59,"phases":60,"briefSummary":62,"conditions":63,"keywords":65,"overallStatus":69,"whyStopped":20,"lastUpdateSubmitDate":70,"lastUpdatePostDateStruct":71,"startDateStruct":74,"completionDateStruct":76,"leadSponsor":78,"locationsCount":79},{"fullName":5,"class":6},"Adagio Medical","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"VT Cryoablation Arm","EXPERIMENTAL","all subjects will receive a cryoablation procedure with the VT System and be followed up for 6-month",[13],"Device: VT Cryoablation System",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DEVICE","VT Cryoablation System","All subjects will receive a cryoablation procedure using the VT Cryoablation System (catheter, stylets, and console)",[9],null,[22,27],{"name":23,"role":24,"phone":25,"phoneExt":20,"email":26},"Nabil Jubran","CONTACT","(949) 348-1188","njubran@adagiomedical.com",{"name":28,"role":24,"phone":25,"phoneExt":20,"email":29},"Doug Kurschinski","dkurschinski@adagiomedical.com",[31],{"facility":32,"status":20,"city":33,"state":34,"zip":35,"country":36,"cosmosGeoPoint":37,"geoPoint":42,"contacts":43},"Essex Cardiothoracic Centre","Basildon","Essex","SS16 5NL","United Kingdom",{"type":38,"coordinates":39},"Point",[40,41],0.45782,51.56844,{"lat":41,"lon":40},[44],{"name":45,"role":24,"phone":20,"phoneExt":20,"email":20},"Neil Srinivasan",{"type":47,"investigatorFullName":20,"investigatorTitle":20,"investigatorAffiliation":20,"oldNameTitle":20,"oldOrganization":20},"SPONSOR","100545645",false,"NCT06384599","VT Cryoablation System Post-Market Clinical Follow-up (PMCF) Study","Adagio Medical VT Cryoablation System Post-Market Clinical Follow-up (PMCF) Study","Inclusion Criteria:\n\n* IC 1 Male or female the ages of ≥ 18 years\n* IC 2 Planned ablation procedure according to the indication for use of the Adagio VT Cryoablation System\n* IC 3 Subject willing to comply with study requirements and give informed consent\n* IC4 Subject has or will be receiving an ICD prior to hospital discharge\n\nExclusion Criteria:\n\n* EC 1 In the opinion of the investigator, any known contraindication to a ventricular tachycardia procedure with the Adagio VT Cyroablation System as indicated in the device Instructions For Use (IFU)\n* EC 2 Subject is enrolled in a study that has not been approved for concurrent enrollment by the sponsor\n* EC 3 Any other condition that, in the judgement of the investigator, makes the patient a poor candidate for this procedure, the study or compliance with the protocol (includes vulnerable patient population, mental illness, addictive disease, terminal illness with a life expectancy of less than six months, extensive travel away from the research center)","ALL","18 Years",{"count":57,"type":58},130,"ESTIMATED","INTERVENTIONAL",[61],"NA","The PMCF is a prospective, single-arm, multi-center, controlled study of up to 130 patients designed to collect safety and performance data regarding the use of the Adagio VT Cryoablation System in the treatment of recurrent ventricular tachycardia.",[64],"Ventricular Tachycardia",[66,67,68],"Monomorphic Ventricular Tachycardia","VT","Cryoablation","NOT_YET_RECRUITING","2026-04-06",{"date":72,"type":73},"2026-04-09","ACTUAL",{"date":75,"type":58},"2026-09-01",{"date":77,"type":58},"2027-09-01",{"name":5,"class":6},1]